Objective assessment of suicide risk: Significant improvements in assessment, classification, and prediction

American Journal of Psychiatry

Volumn 168, Issue 12, 2011, Pages 1233-1234

  Hughes, Carroll W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

CLINICAL PRACTICE; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG USE; EDITORIAL; HIGH RISK PATIENT; HUMAN; PATIENT ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; PSYCHOLOGIC ASSESSMENT; PSYCHOMETRY; RISK ASSESSMENT; RISK FACTOR; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; FEMALE; HOSPITALIZATION; MALE; NOTE; PSYCHOLOGICAL ASPECT; SUICIDE;

FEMALE; HUMANS; MALE; SEVERITY OF ILLNESS INDEX; SUICIDAL IDEATION; SUICIDE;

EID: 84857099258     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2011.11091362     Document Type: Editorial

References (7)

1. Brent DA: Preventing youth suicide: time to ask how. J Am Acad Child Adolesc Psychiatry 2011; 50:738-740
2. US Food and Drug Administration, Center for Drug Evaluation and Research: Guidance for Industry: Suicidality: Prospective Assessment of Occurrence in Clinical Trials: Draft. Sept 2010. www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM225130.pdf
3. Meyer RE, Salzman C, Youngstrom EA, Clayton PJ, Goodwin FK, Mann JJ, Alphs LD, Broich K, Goodman WK, Greden JF, Meltzer HY, Normand SL, Posner K, Shaffer D, Oquendo MA, Stanley B, Trivedi MH, Turecki G, Beasley CM Jr, Beautrais AL, Bridge JA, Brown GK, Revicki DA, Ryan ND, Sheehan DV: Suicidality and risk of suicide: definition, drug safety concerns, and a necessary target for drug development: a brief report. J Clin Psychiatry 2010; 71:1040-1046
4. Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, Currier GW, Melvin GA, Greenhill L, Shen S, Mann JJ: The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry 2011; 168:1266-1277
5. Posner K, Oquendo MA, Gould M, Stanley B, Davies M: Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry 2007; 164:1035-1043 (Pubitemid 47121392)
6. Asarnow JR, Porta G, Spirito A, Emslie G, Clarke G, Wagner KD, Vitiello B, Keller M, Birmaher B, McCracken J, Mayes T, Berk M, Brent DA: Suicide attempts and nonsuicidal self-injury in the treatment of resistant depression in adolescents: findings from the TORDIA study. J Am Acad Child Adolesc Psychiatry 2011; 50:772-781
7. Brent DA, Greenhill LL, Compton S, Emslie G, Wells K, Walkup JT, Vitiello B, Bukstein O, Stanley B, Posner K, Kennard BD, Cwik MF, Wagner A, Coffey B, March JS, Riddle M, Goldstein T, Curry J, Barnett S, Capasso L, Zelazny J, Hughes J, Shen S, Gugga SS, Turner JB: The Treatment of Adolescent Suicide Attempters Study (TASA): predictors of suicidal events in an open treatment trial. J Am Acad Child Adolesc Psychiatry 2009; 48:987-996